Tech Company Financing Transactions

Biodel Funding Round

Biodel, based in Danbury, secured $21 million from Great Point Partners, OrbiMed and Vivo Capital.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

100 Saw Mill Rd.
Danbury, CT 06810
USA

Phone

(203) 796-5000

Website

www.biodel.com

Email Address

[email protected]

Overview

Biodel Inc. is a specialty pharmaceutical company that develops novel formulations of FDA approved therapeutics to treat endocrine disorders such as diabetes. Biodel's products are created by utilizing the company's proprietary VIAdel technology.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Solomon Steiner

        

Chief Financial Officer

Gerard Michel

        

Chief Medical Officer

Alan Krasner

        

Browse more venture capital transactions:

Prev: 8/2/2006: ESBATech AG venture capital transaction
Next: 8/2/2006: Esprit Pharma venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We report on every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary